Ruta de navegación
Documentos y multimedia
Introducing the Treatment Hierarchy Question in Network Meta-Analysis
Introducing the Treatment Hierarchy Question in Network Meta-Analysis
Versión 1.0 Aprobado
- Tipo del documento
- EXTERNAL_DOCUMENT
- Extensión
- png
- Tamaño
- 139 KB
- Modificado
- 21/10/22 13:28 por mir mir
- Creado
- 21/10/22 13:28 por mir mir
- Localización
- PUBLIC
- Valoraciones
-
-
Versión 1.0Por mir mir, en 21/10/22 13:28Registro sin cambios
Resumen
Comparative effectiveness research using network meta-analysis can present a hierarchy of competing treatments, from the most to the least preferable option. However, in published reviews, the research question associated with the hierarchy of multiple interventions is typically not clearly defined. Here we introduce the novel notion of a treatment hierarchy question that describes the criterion for choosing a specific treatment over one or more competing alternatives. For example, stakeholders might ask which treatment is most likely to improve mean survival by at least 2 years, or which treatment is associated with the longest mean survival. We discuss the most commonly used ranking metrics (quantities that compare the estimated treatment-specific effects), how the ranking metrics produce a treatment hierarchy, and the type of treatment hierarchy question that each ranking metric can answer. We show that the ranking metrics encompass the uncertainty in the estimation of the treatment effects in different ways, which results in different treatment hierarchies. When using network meta-analyses that aim to rank treatments, investigators should state the treatment hierarchy question they aim to address and employ the appropriate ranking metric to answer it. Following this new proposal will avoid some controversies that have arisen in comparative effectiveness research.

El proyecto COMPAR-EU ha recibido financiación del programa de investigación e innovación Horizont 2020 de la Unión Europea en virtud del acuerdo de subvención nº 754936.
Tenga en cuenta que ésta es la versión beta de la plataforma COMPAR-EU. Ahora incluye los resultados completos para Diabetes y durante todo el verano de 2022 se completarán los resultados para Obesidad, EPOC e Insuficiencia Cardíaca. La plataforma también se ampliará y mejorará en los próximos meses.